Temazepam

Benzodiazepineprescriptionoral · inferred

Short-acting 3-hydroxy benzodiazepine. Clinical hypnotic (Restoril) AND minor active metabolite of diazepam (CYP3A4-mediated). t½ ~10 h.

Projected serum levels — 15 mg, once daily

Temazepam
Temazepam modeled serum levels, 15 mg once daily over 15 days Population-based pharmacokinetic estimate. Steady state reached after approximately 1 days. 0 5 10 15 20 Day 0 Day 4 Day 8 Day 11 Day 15 Time on a regular schedule ≈ steady state · day 1

Maintenance schedule: 15 mg once daily (oral).

Modeled steady state after ~1 days: peak ≈ 11.0 mg, trough ≈ 0.19 mg body load. Population-based estimate over 15 days for a 15 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.

Key facts

Category
Benzodiazepine
Route modeled
Oral
Model confidence
inferred
Half-life
10 h
Common dose
15 mg
Suggested maximum
30 mg/day
Reference dose range
7.5–30 mg (single dose)
Suggested cadence
once daily
Validated against
30 mg oral — Cmax 0.90 mg/L at 1.2 h

Documented interactions

  • watch
    GABA (Gamma-Aminobutyric Acid) + Temazepam Stacked effects

    GABA (Gamma-Aminobutyric Acid) and Temazepam both push the gaba a in the same direction.

  • watch
    Ivermectin (Stromectol) + Temazepam Stacked effects

    Ivermectin (Stromectol) and Temazepam both push the gaba a in the same direction.

  • watch
    L-Theanine + Temazepam Stacked effects

    L-Theanine and Temazepam both push the gaba a in the same direction.

  • watch
    Taurine + Temazepam Stacked effects

    Taurine and Temazepam both push the gaba a in the same direction.

Serum checks 4 modeled interaction pairings for temazepam across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.